Search research articles
Contact Us
Filters
Showing results (41-50 of 152) with videos related to
Page
of 16
Sort By:
Journal of Hepatology
|
February 26, 2011
Causality assessment methods in drug induced liver injury: strengths and weaknesses
Miren García-Cortés, Camilla Stephens, M Isabel Lucena, et al.
European Journal of Clinical Pharmacology
|
April 10, 2003
Drug use for non-hepatic associated conditions in patients with liver cirrhosis
M Isabel Lucena, Raúl J Andrade, Gianni Tognoni, et al.
European Journal of Clinical Pharmacology
|
September 21, 2002
Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis
M Isabel Lucena, Raúl J Andrade, Gianni Tognoni, et al.
Seminars in Liver Disease
|
February 23, 2018
Hepatic Damage by Natural Remedies
Raul J Andrade, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, et al.
The Annals of Pharmacotherapy
|
November 25, 2003
Lansoprazole-induced hepatic dysfunction
Miren García-Cortés, M Isabel Lucena, Raúl J Andrade, et al.
Journal of Hepatology
|
December 2, 2022
Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but different HLA risk alleles in an independent cohort
Ann K Daly, Einar S Bjornsson, M Isabel Lucena, et al.
Seminars in Liver Disease
|
May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
Fernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
World Journal of Gastroenterology
|
August 29, 2006
Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report
M Isabel Lucena, Raúl J Andrade, Luis Vicioso, et al.
Archives of Toxicology
|
August 28, 2020
Drug induced liver injury: an update
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
Current Drug Safety
|
August 12, 2008
Genetic and molecular factors in drug-induced liver injury: a review
Ketevan Pachkoria, M Isabel Lucena, Mariam Molokhia, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 152) with videos related to
Sort By:
Page
of 16
Journal of Hepatology
|
February 26, 2011
Causality assessment methods in drug induced liver injury: strengths and weaknesses
Miren García-Cortés, Camilla Stephens, M Isabel Lucena, et al.
European Journal of Clinical Pharmacology
|
April 10, 2003
Drug use for non-hepatic associated conditions in patients with liver cirrhosis
M Isabel Lucena, Raúl J Andrade, Gianni Tognoni, et al.
European Journal of Clinical Pharmacology
|
September 21, 2002
Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis
M Isabel Lucena, Raúl J Andrade, Gianni Tognoni, et al.
Seminars in Liver Disease
|
February 23, 2018
Hepatic Damage by Natural Remedies
Raul J Andrade, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, et al.
The Annals of Pharmacotherapy
|
November 25, 2003
Lansoprazole-induced hepatic dysfunction
Miren García-Cortés, M Isabel Lucena, Raúl J Andrade, et al.
Journal of Hepatology
|
December 2, 2022
Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but different HLA risk alleles in an independent cohort
Ann K Daly, Einar S Bjornsson, M Isabel Lucena, et al.
Seminars in Liver Disease
|
May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
Fernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
World Journal of Gastroenterology
|
August 29, 2006
Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report
M Isabel Lucena, Raúl J Andrade, Luis Vicioso, et al.
Archives of Toxicology
|
August 28, 2020
Drug induced liver injury: an update
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
Current Drug Safety
|
August 12, 2008
Genetic and molecular factors in drug-induced liver injury: a review
Ketevan Pachkoria, M Isabel Lucena, Mariam Molokhia, et al.
Page
of 16